A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI(3)K-Akt signalling

Nature Cell Biology

Volumn 8, Issue 8, 2006, Pages 834-842

  Fallon, Lara ^a   Bélanger, Catherine M L ^a   Corera, Amadou T ^a   Kontogiannea, Maria ^a   Regan Klapisz, Elsa ^b   Moreau, France ^a   Voortman, Jarno ^b   Haber, Michael ^a   Rouleau, Geneviève ^a   Thorarinsdottir, Thorhildur ^a   Brice, Alexis ^c   van Bergen en Henegouwen, Paul M P ^b   Fon, Edward A ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UTRECHT UNIVERSITY   (Netherlands)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR PATHWAY SUBSTRATE 15; HYBRID PROTEIN; IODINE 125; PARKIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEASOME; PROTEIN KINASE B;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN; CELL STRAIN COS7; CELL STRAIN HEK293; CELL SURVIVAL; CELL TRANSPORT; ENDOCYTOSIS; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; IN VITRO STUDY; ISOTOPE LABELING; KNOCKOUT MOUSE; MOUSE; NERVE CELL; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UBIQUITINATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; BLOTTING, WESTERN; CELL LINE; CERCOPITHECUS AETHIOPS; COS CELLS; ENDOCYTOSIS; EPIDERMAL GROWTH FACTOR; HELA CELLS; HUMANS; IMMUNOPRECIPITATION; MICE; MICE, KNOCKOUT; NIH 3T3 CELLS; PROTEIN BINDING; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TRANSFECTION; UBIQUITIN-PROTEIN LIGASES;

EID: 33746594215     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncb1441     Document Type: Article

References (35)

1. Kitada, T. et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392, 605-608 (1998).
2. Lucking, C. B. et al. Association between early-onset Parkinson's disease and mutations in the parkin gene. French Parkinson's Disease Genetics Study Group. N. Engl. J. Med. 342, 1560-1567 (2000).
3. Shimura, H. et al. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nature Genet. 25, 302-305 (2000).
4. Moore, D. J., West, A. B., Dawson, V. L. & Dawson, T. M. Molecular pathophysiology of Parkinson's disease. Annu. Rev. Neurosci. 28, 57-87 (2005).
5. Confalonieri, S., Salcini, A. E., Puri, C., Tacchetti, C. & Di Fiore, P. P. Tyrosine phosphorylation of Eps15 is required for ligand-regulated, but not constitutive, endocytosis. J. Cell Biol. 150, 905-912 (2000).
6. Sigismund, S. et al. Clathrin-independent endocytosis of ubiquitinated cargos. Proc. Natl Acad. Sci. USA 102, 2760-2765 (2005).
7. de Melker, A. A., van der Horst, G. & Borst, J. c-Cbl directs EGF receptors into an endocytic pathway that involves the ubiquitin-interacting motif of Eps15. J. Cell Sci. 117, 5001-5012 (2004).
8. Hoeller, D. et al. Regulation of ubiquitin-binding proteins by monoubiquitination. Nature Cell Biol. 8, 163-169 (2006).
9. Brunet, A., Datta, S. R. & Greenberg, M. E. Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr. Opin. Neurobiol. 11, 297-305 (2001).
10. Hershko, A. & Ciechanover, A. The ubiquitin system. Annu. Rev. Biochem. 67, 425-479 (1998).
11. Goldberg, M. S. et al. Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J. Biol. Chem. 278, 43628-43635 (2003).
12. Ko, H. S. et al. Accumulation of the authentic parkin substrate aminoacyl-tRNA synthetase cofactor, p38/JTV-1, leads to catecholaminergic cell death. J. Neurosci. 25, 7968-7978 (2005).
13. Periquet, M., Corti, O., Jacquier, S. & Brice, A. Proteomic analysis of parkin knockout mice: Alterations in energy metabolism, protein handling and synaptic function. J. Neurochem. 95, 1259-1276 (2005).
14. Young, P., Deveraux, Q., Beal, R. E., Pickart, C. M. & Rechsteiner, M. Characterization of two polyubiquitin binding sites in the 26 S protease subunit 5a. J. Biol. Chem. 273, 5461-5467 (1998).
15. Walters, K. J., Kleijnen, M. F., Goh, A. M., Wagner, G. & Howley, P. M. Structural studies of the interaction between ubiquitin family proteins and proteasome subunit S5a. Biochemistry 41, 1767-1777 (2002).
16. Hicke, L. & Dunn, R. Regulation of membrane protein transport by ubiquitin and ubiquitin-binding proteins. Annu. Rev. Cell. Dev. Biol. 19, 141-172 (2003).
17. Polo, S. et al. A single motif responsible for ubiquitin recognition and monoubiquitination in endocytic proteins. Nature 416, 451-455 (2002).
18. Klapisz, E. et al. A ubiquitin-interacting motif (UIM) is essential for Eps15 and Eps15R ubiquitination. J. Biol. Chem. 277, 30746-30753 (2002).
19. Di Fiore, P. P., Polo, S. & Hofmann, K. When ubiquitin meets ubiquitin receptors: A signalling connection. Nature Rev. Mol. Cell. Biol. 4, 491-497 (2003).
20. Fazioli, F., Minichiello, L., Matoskova, B., Wong, W. T. & Di Fiore, P. P. eps15, a novel tyrosine kinase substrate, exhibits transforming activity. Mol. Cell. Biol. 13, 5814-5828 (1993).
21. van Delft, S., Govers, R., Strous, G. J., Verkleij, A. J. & van Bergen en Henegouwen P. M. Epidermal growth factor induces ubiquitination of Eps15. J. Biol. Chem. 272, 14013-14016 (1997).
22. Cesari, R. et al. Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27. Proc. Natl Acad. Sci. USA 100, 5956-5961 (2003).
23. Denison, S. R. et al. Alterations in the common fragile site gene Parkin in ovarian and other cancers. Oncogene 22, 8370-8378 (2003).
24. Pawlyk, A. C. et al. Novel monoclonal antibodies demonstrate biochemical variation of brain parkin with age. J. Biol. Chem. 278, 48120-48128 (2003).
25. Huang, F., Khvorova, A., Marshall, W. & Sorkin, A. Analysis of clathrin-mediated endocytosis of epidermal growth factor receptor by RNA interference. J. Biol. Chem. 279, 16657-16661 (2004).
26. Katzmann, D. J., Odorizzi, G. & Emr, S. D. Receptor downregulation and multivesicular-body sorting. Nature Rev. Mol. Cell. Biol. 3, 893-905 (2002).
27. Torrisi, M. R. et al. Eps15 is recruited to the plasma membrane upon epidermal growth factor receptor activation and localizes to components of the endocytic pathway during receptor internalization. Mol. Biol. Cell 10, 417-434 (1999).
28. Faundez, V., Krauss, R., Holuigue, L., Garrido, J. & Gonzalez, A. Epidermal growth factor receptor in synaptic fractions of the rat central nervous system. J. Biol. Chem. 267, 20363-20370 (1992).
29. Fallon, L. et al. Parkin and CASK/LIN-2 associate via a PDZ-mediated interaction and are co-localized in lipid rafts and postsynaptic densities in brain. J. Biol. Chem. 277, 486-491 (2002).
30. Koprivica, V. et al. EGFR activation mediates inhibition of axon regeneration by myelin and chondroitin sulfate proteoglycans. Science 310, 106-110 (2005).
31. Iwakura, Y. et al. Influences of dopaminergic lesion on epidermal growth factor-ErbB signals in Parkinson's disease and its model: Neurotrophic implication in nigrostriatal neurons. J. Neurochem. 93, 974-983 (2005).
32. Kim, R. H. et al. DJ-1, a novel regulator of the tumor suppressor PTEN. Cancer Cell 7, 263-273 (2005).
33. Yang, Y. et al. Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling. Proc. Natl Acad. Sci. USA 102, 13670-13675 (2005).
34. Lim, K. L. et al. Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: Implications for Lewy body formation. J. Neurosci. 25, 2002-2009 (2005).
35. Hicks, A. A. et al. A susceptibility gene for late-onset idiopathic Parkinson's disease. Ann. Neurol. 52, 549-555 (2002).